Greene Barry E

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$2.28M
Insider Sells Quantity
18
Insider Sells Sum
$81.23M

Insider Activity of Greene Barry E

The largest purchase of all time was on 2021-08-05 and amounted to 23640 shares of Sage Therapeutics, Inc. for $1.02M.

The largest sale of all time was on 2017-09-20 and amounted to 153630 shares of Alnylam Pharmaceuticals, Inc. for $15.36M.

Biography of Greene Barry E

No biography is available at this moment.

2022-11-10PurchaseSage Therapeutics, Inc.
SAGE
President and CEO
14,500
0.024%
$34.48$500,022+19.18%
2021-08-05PurchaseSage Therapeutics, Inc.
SAGE
President and CEO
23,640
0.0401%
$43.15$1.02M-10.58%
2021-06-16PurchaseSage Therapeutics, Inc.
SAGE
President and CEO
8,800
0.0154%
$56.32$495,627-24.87%
2020-09-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
44,530
0.0384%
$123.23$5.49M+16.3%
2020-07-07SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
22,265
0.0192%
$159.99$3.56M-12.51%
2020-05-06SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
22,265
0.02%
$149.99$3.34M-4.35%
2019-10-22SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
58,913
0.0532%
$89.99$5.3M+45.29%
2018-03-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
76,920
0.0776%
$143.10$11.01M-34.38%
2017-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
170,632
0.1062%
$73.17$12.49M-5.49%
2017-09-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
153,630
0.147%
$100.00$15.36M+2.82%
2016-12-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
63,650
0.0767%
$42.99$2.74M+73.81%
2015-05-26SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
134,758
0.0863%
$69.06$9.31M-30.86%
2015-04-02PurchaseKaryopharm Therapeutics Inc.
KPTI
director
6,000
0.0167%
$29.31$175,877-51.65%
2014-12-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
22,400
0.0299%
$100.00$2.24M+4.47%
2014-11-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
66,400
0.09%
$89.63$5.95M+17.69%
2014-11-11SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
22,200
0.0162%
$53.39$1.19M+6.35%
2013-05-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
22,822
0.0248%
$19.95$455,339+93.71%
2013-03-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
President & COO
48,116
0.0422%
$12.97$624,305+115.11%
2013-03-08SaleAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
48,000
0.0419%
$12.69$609,070+115.83%
2012-02-21PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
President and COO
3,720
0.0072%
$10.75$39,990+41.4%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.